Matching mechanisms and therapeutics: new avenues to explore

Ione Woollacott, MD, MRCP from the Institute of Neurology, University College London, London, UK discusses the work she presented at the 2017 Alzheimer’s Association International Conference (AAIC) in London, UK, regarding imaging changes in familial frontotemporal dementia (FTD) and the rates of systemic autoimmune diseases. Dr Woollacott also tells us why she was particularly excited about the focus of this year’s conference, and the implications it could have for future FTD therapies.

Share this video